"Hamilton Dermatology is a state-of-the-art medical office owned by Dr. Tiffani Hamilton in Alpharetta, Georgia. We pride ourselves on offering the most advanced cosmetic techniques in the industry. As a research facility, we are able to give our patients the newest and most effective treatments available for all types of skin conditions. We are committed to the goal of constantly providing the highest quality, up-to-date medical care for our patients. Dr. Hamilton is world-renowned for the use of injectable fillers. She actively participates in clinical trials, and is nationally known for the the treatment of psoriasis."

During the past decade, Atlanta Dermatology, Vein & Research Center, LLC conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 18 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlanta Dermatology, Vein & Research Center, LLC" #1 sponsor was "Amgen" with 6 trials, followed by "Peplin" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Galderma R&D" with 3 trials sponsored and "Janssen Research & Development, LLC" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlanta Dermatology, Vein & Research Center, LLC" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator, "Rho, Inc." with 1 trials as a collaborator and "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Atlanta Dermatology, Vein & Research Center, LLC" are "Psoriasis" (14 trials), "Plaque Psoriasis" (5 trials), "Actinic Keratosis" (3 trials), "Acne Vulgaris" (2 trials) and "Psoriasis Vulgaris" (2 trials). Many other conditions were trialed in "Atlanta Dermatology, Vein & Research Center, LLC" in a lesser frequency.

Most popular intervention types in "Atlanta Dermatology, Vein & Research Center, LLC" are "Drug" (29 trials), "Other" (5 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Apremilast" (2 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Atlanta Dermatology, Vein & Research Center, LLC" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Atlanta Dermatology, Vein & Research Center, LLC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Atlanta Dermatology, Vein & Research Center, LLC, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Atlanta Dermatology, Vein & Research Center, LLC, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".